<DOC>
	<DOCNO>NCT01205620</DOCNO>
	<brief_summary>Participants undergo Off-CABG randomize 1:1 one follow group : - treatment CirQlator TM Intrathoracic Pressure Regulator ( ITPR ) - ITPR .Anesthesia standardize group . The group compare base difference vasopressor use , number amount ( milliliter ) intravenous fluid bolus require hemodynamic change note , include systemic blood pressure , pulmonary arterial pressure , pulse pressure , heart rate ( record reliably arterial line ) , cardiac output ( CO ) , cardiac index ( CI ) , mixed venous oxygen saturation ( SVO2 ) , SVR , pulmonary vascular resistance ( PVR ) , stroke volume ( SV ) . Specifically , compare group base mean number intravenous fluid bolus , mean amount norepinephrine epinephrine infusion require , number record systolic blood pressure &lt; 90 mmHg , number CI &lt; 2.0 L/min/m2 . We also compare number time surgeon must reposition heart treatment hypotension , ascertain whether ITPR help patient tolerate cardiac displacement well , thus decrease time required complete bypass graft anastamosis . ECG monitor intraoperatively sign ischemia include ST change , great 1mm depression elevation . Postoperatively , record need amount diuretic require . We hypothesize pilot study , patient undergo OPCAB treat CirQlator TM Intrathoracic Pressure Regulator ( ITPR ) achieve high blood pressure cardiac output require less intravenous fluid vasopressor administration patient manage without ITPR .</brief_summary>
	<brief_title>IRB-HSR # 15084 A Prospective , Unblinded , Controlled Study Evaluate Effect ITPR Patients Undergoing OPCAB Surgery</brief_title>
	<detailed_description>A new method improve cardiac performance OPCAB surgery need order avoid administration large amount intravenous volume , reduce vasopressor medication , thus improve cardiac function reduce need postoperative diuresis . The CirQlator TM Intrathoracic Pressure Regulator ( ITPR ) FDA-approved device intend increase circulation blood pressure hypovolemic cardiogenic shock . The device insert within standard respiratory circuit patient ventilator . It function decrease intrathoracic pressure expiratory phase subatmospheric level positive pressure ventilation . The decrease intrathoracic pressure create vacuum within thorax relative rest body thereby enhance blood return heart consequently increase cardiac output blood pressure . Activation device also accompany decrease systemic vascular resistance ( SVR ) . The end result device simultaneously improve cardiac output increase preload decrease systemic vascular resistance ( SVR ) increase coronary perfusion pressure increase blood pressure decrease leave ventricular end systolic pressure volume ( LVESP/LVESV ) .7-14</detailed_description>
	<criteria>patient present elective offpump CABG age 18 year age old informed consent obtain Patients planned pump CABG patient require IABP VAD preoperatively emergent CABG pneumothorax hemothorax uncontrolled bleeding uncontrolled hypertension define SBP &gt; 180 mmHg time surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>CABG</keyword>
</DOC>